Calton & Associates’s Innoviva INVA Stock Holding History

Calton & Associates’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,300	Closed	-$51K	–	803
2017 Q4	$51K	Buy	+3,300	New	+$44K	0.01%	676

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Calton & Associates's INVA Position: Q1 2018 in Review

Calton & Associates sold out of Innoviva (INVA) in Q1 2018, closing a stake of 3,300 shares — an estimated $51K sold.

Calton & Associates first reported a position in INVA in Q4 2017 and held it in 1 quarter. The position peaked at $51K in Q4 2017. 223 funds tracked by Wall St. Rank hold INVA as of Q1 2018.

Calton & Associates reported no remaining Innoviva position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 3,300 Innoviva shares in Q1 2018, an estimated $51K.
Calton & Associates first reported a position in Innoviva in Q4 2017 and held it in 1 quarter.
Calton & Associates's Innoviva position peaked at $51K in Q4 2017.
223 funds tracked by Wall St. Rank held Innoviva as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.